BioSpace News Archive

Genetown

IARPA Awards B24IC Research Contract to Ginkgo Bioworks to Develop Breakthrough Biointelligence and Biosecurity Innovations

Ginkgo Bioworks has been awarded a research contract from the Intelligence Advanced Research Projects Activity (IARPA), the research and development arm of the U.S. Intelligence Community, for the Biointelligence and Biosecurity for the Intelligence Community (B24IC) program.

July 13, 2023
·
7 min read
Business

Verasonics Expands Scientific Advisory Board (SAB)

Verasonics, Inc., the leader in research ultrasound, announced today that it has expanded its Scientific Advisory Board (SAB) to include nine additional members with valuable expertise in the fields of biomedical engineering and Materials Science.

July 13, 2023
·
2 min read
Business

Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Update

Aeterna Zentaris Inc. today provided an update on its therapeutic and diagnostic development pipeline programs and outlined upcoming key milestones.

July 13, 2023
·
10 min read
Deals

Revelation Pharma Completes Two Acquisitions

Osceola Capital announced today the seventeenth and eighteenth additions to the Revelation Pharma (“Revelation” or the “Company”) platform, adding significant scale and capabilities to the business.

July 13, 2023
·
2 min read
Business

Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference

Olink Holding AB announced it will release financial results for the second quarter of 2023 before the market open on Wednesday, August 9, 2023.

July 13, 2023
·
1 min read
Recce Pharmaceuticals Receives A$801,604 Research and Development (R&D) Rebate Advance

Recce Pharmaceuticals Ltd is pleased to announce it received further non-dilutive funds from Radium Capital for A$801,604 of Recce’s future R&D tax incentive.

July 13, 2023
·
2 min read
Business

Alignment Healthcare to Announce Second Quarter 2023 Financial Results and Host Conference Call Thursday, Aug. 3, 2023

Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, will release its second quarter 2023 financial results on Thursday, Aug. 3, after market close.

July 13, 2023
·
1 min read
Genetown

Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in ChinaAcceptance of NDA Submission triggers as $2 million milestone payment to Ardelyx by Fosun Pharma

Ardelyx, Inc. today announced that a New Drug Application (NDA) for tenapanor has been accepted for review by China’s Center for Drug Evaluation of the National Medical Products Administration (NMPA) for the control of serum phosphorus in adult patients with chronic kidney disease on hemodialysis.

July 13, 2023
·
5 min read
Biotech Bay

ProSomnus to Design Head-to-Head Clinical Trial vs. Hypoglossal Nerve Stimulation

ProSomnus, Inc., a leading CPAP alternative for the treatment of Obstructive Sleep Apnea, announced plans to design a head-to-head clinical trial comparing its precision oral appliance therapy and hypoglossal nerve stimulation in treating patients with severe OSA.

July 13, 2023
·
4 min read
Drug Development

Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis

Incannex Healthcare Limited is pleased to announce that it has received approval from Bellberry Human Research Ethics Committee (‘HREC’) for the lead site, Emeritus Research, Camberwell, Victoria, for its Phase 2 clinical trial.

July 13, 2023
·
10 min read